Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
17.77
+0.85 (5.02%)
At close: Feb 21, 2025, 4:00 PM
17.75
-0.02 (-0.11%)
After-hours: Feb 21, 2025, 7:10 PM EST
ARCT Market Cap
ARCT has a market cap or net worth of $481.34 million as of February 21, 2025. Its market cap has decreased by -52.29% in one year.
Market Cap
481.34M
Enterprise Value
273.59M
1-Year Change
-52.29%
Ranking
Category
Stock Price
$17.77
Market Cap Chart
Since October 22, 2013, ARCT's market cap has increased from $222.10M to $481.34M, an increase of 116.72%. That is a compound annual growth rate of 7.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 481.30M | 4.70% |
Dec 31, 2024 | 459.70M | -45.44% |
Dec 29, 2023 | 842.60M | 87.54% |
Dec 30, 2022 | 449.30M | -53.95% |
Dec 31, 2021 | 975.60M | -8.18% |
Dec 31, 2020 | 1.06B | 546.29% |
Dec 31, 2019 | 164.40M | 238.97% |
Dec 31, 2018 | 48.50M | 54.95% |
Dec 29, 2017 | 31.30M | -45.94% |
Dec 30, 2016 | 57.90M | -32.75% |
Dec 31, 2015 | 86.10M | 69.16% |
Dec 31, 2014 | 50.90M | -79.27% |
Dec 31, 2013 | 245.50M | 10.54% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |